Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic.
Dermatol Online J
; 26(10)2020 Oct 15.
Article
in English
| MEDLINE | ID: covidwho-908494
ABSTRACT
Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential risk of SARS-CoV-2 infection. This article includes an overview of the up-to-date international and U.S. treatment guidelines for psoriasis, atopic dermatitis, hidradenitis suppurativa, and acne/rosacea; it provides tables summarizing these resources to assist providers and patients in remaining updated regarding recommended treatment modifications during the pandemic (See Tables 1-4).
Search on Google
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Psoriasis
/
Hidradenitis Suppurativa
/
Rosacea
/
Coronavirus Infections
/
Dermatitis, Atopic
/
Betacoronavirus
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal subject:
Dermatology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS